Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$141,254,543
+$15,166,144 QoQ
Shares Held
1,500,792
+17.6% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. INCY ranks #2 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
This page
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141,254,543 | 1,500,792 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $126,088,399 | 1,276,586 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $64,144,008 | 756,326 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $51,839,558 | 761,227 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $46,825,010 | 773,328 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $65,490,861 | 948,181 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $75,658,060 | 1,144,600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $75,414,189 | 1,244,048 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $50,931,521 | 894,006 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $57,663,698 | 918,358 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $46,752,625 | 809,289 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $46,487,117 | 746,781 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $234,150,030 | 3,239,934 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $271,073,494 | 3,374,919 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $65,805,267 | 987,474 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $243,153,760 | 3,200,655 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $72,253,298 | 909,762 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $73,791,956 | 1,005,340 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $73,502,916 | 1,068,667 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $81,571,017 | 969,583 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $78,961,119 | 971,590 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $78,024,626 | 897,041 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $100,834,107 | 1,123,625 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $201,578,907 | 1,938,818 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $85,137,857 | 1,162,609 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||